Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Snedecor (1967)
STATISTICAL METHODSActa Pædiatrica, 56
J. Eble (1964)
A PROPOSED MECHANISM FOR THE DEPRESSOR EFFECT OF DOPAMINE IN THE ANESTHETIZED DOG.The Journal of pharmacology and experimental therapeutics, 145
A. Watanabe, T. Chase, P. Cardon (1970)
Effect of L‐dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexesClinical Pharmacology & Therapeutics, 11
S. Mohammed, A. Fasola, P. Privitera, R. Lipicky, B. Martz, T. Gaffney (1969)
Effect of Methyldopa on Plasma Renin Activity in ManCirculation Research, 25
M. Blaufox, A. Birbari, R. Hickler, J. Merrill (1966)
Peripheral plasma renin activity in renal-homotransplant recipients.The New England journal of medicine, 275 21
A. Watanabe, L. Parks, I. Kopin (1971)
Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.The Journal of clinical investigation, 50 6
Roger Boucher, R. Veyrat, J. DeChamplain, Jacques Genest (1964)
NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS.Canadian Medical Association journal, 90
A. Michelakis, D. Robertson (1970)
Plasma renin activity and levodopa in Parkinson's disease.JAMA, 213 1
G. Cotzias, P. Papavasiliou, R. Gellene (1969)
Modification of Parkinsonism--chronic treatment with L-dopa.The New England journal of medicine, 280 7
T. Whitsett, P. Halushka, L. Goldberg (1970)
Attenuation of Postganglionic Sympathetic Nerve Activity by L‐DopaCirculation Research, 27
M. Henning, A. Rubenson (1970)
Central hypotensive effect of L‐3,4‐dihydroxyphenylalanine in the ratJournal of Pharmacy and Pharmacology, 22
B. Kliman, R. Peterson (1960)
Double isotope derivative assay of aldosterone in biological extracts.The Journal of biological chemistry, 235
A. Barbeau, L. Gillo-Joffroy, R. Boucher, W. Nowaczynski, J. Genest (1969)
Renin-Aldosterone System in Parkinson's DiseaseScience, 165
G. Finlay, T. Whitsett, E. Cucinell, L. Goldberg (1971)
Augmentation of sodium and potassium excretion, glomerular filtration rate and renal plasma flow by levodopa.The New England journal of medicine, 284 15
G. Williams, L. Rose, R. Dluhy, D. McCaughn, P. Jagger, R. Hickler, D. Lauler (1970)
Abnormal responsiveness of the renin aldosterone system to acute stimulation in patients with essential hypertension.Annals of internal medicine, 72 3
P. Weidmann, M. Maxwell, A. Lupu, A. Lewin, S. Massry (1971)
Plasma renin activity and blood pressure in terminal renal failure.The New England journal of medicine, 285 14
J. Abbott, E. Gillespie, Sheila Polakoff, T Pollock, Jean Dolby, M Sterne, J Cameron, A. Griffith, Wellcome, A Beale, P. Muggleton, Hampstead Evans, London, A. Wilson, Henderson, Moore, Heywood, A. Spiers, D. Calnet (1969)
Action of dopamine on the human irisBritish Medical Journal, 4
J. McNay, R. Mcdonald, L. Goldberg (1965)
Direct Renal Vasodilatation Produced by Dopamine in the DogCirculation Research, 16
KK Nakano, Tyler Hr (1971)
A double‐blind study of the effects of levodopa in Parkinson's diseaseNeurology, 21
K. Catt, P. Zimmet, M. Cain, E. Cran, J. Best, J. Coghlan (1971)
Angiotensin II blood-levels in human hypertension.Lancet, 1 7697
Plasma renin activity (PRA) was studied in six patients with Parkinson disease under identical conditions of diet and posture before and after seven days of levodopa administration. Significant differences were not found at seven days, nor when the measurement was repeated under similar conditions of sodium excretion after six months of therapy. The PRA responded appropriately to posture before and after therapy. After six months of therapy, sodium restriction resulted in an appropriate response of PRA and aldosterone secretion. A small but significant fall in blood pressure took place seven days after the initiation of levodopa therapy, at which time PRA had not changed significantly. After six months of therapy, blood pressure had returned to control levels. This study suggests that the renin-aldosterone system is not significantly altered by levodopa therapy of Parkinson disease.
JAMA – American Medical Association
Published: Jun 25, 1973
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.